Treatment of metabolic acidosis in patients with CKD

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Metabolic acidosis is a common complication of chronic kidney disease and is believed to contribute to a number of sequelae, including bone disease, altered protein metabolism, skeletal muscle wasting, and progressive glomerular filtration rate loss. Small trials in animal models and humans suggest a role for alkali therapy to lessen these complications. Recent studies support this notion, although more definitive evidence is needed on the long-term benefits of alkali therapy and the optimal serum bicarbonate level. The role of dietary modification also should be given greater consideration. In addition, potential adverse effects of alkali treatment must be taken into consideration, including sodium retention and the theoretical concern of promoting vascular calcification. This teaching case summarizes the rationale for and benefits and complications of base therapy in patients with chronic kidney disease.

Original languageEnglish (US)
Pages (from-to)311-317
Number of pages7
JournalAmerican Journal of Kidney Diseases
Volume63
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Acidosis
Alkalies
Chronic Renal Insufficiency
Vascular Calcification
Diet Therapy
Bone Diseases
Therapeutics
Bicarbonates
Glomerular Filtration Rate
Teaching
Skeletal Muscle
Animal Models
Sodium
Serum
Proteins

Keywords

  • alkali therapy
  • bicarbonate
  • chronic kidney disease
  • Metabolic acidosis

ASJC Scopus subject areas

  • Nephrology
  • Medicine(all)

Cite this

Treatment of metabolic acidosis in patients with CKD. / Chen, Wei; Abramowitz, Matthew K.

In: American Journal of Kidney Diseases, Vol. 63, No. 2, 02.2014, p. 311-317.

Research output: Contribution to journalArticle

@article{6a6b15a2a3b64578bdcf6e46ff32e227,
title = "Treatment of metabolic acidosis in patients with CKD",
abstract = "Metabolic acidosis is a common complication of chronic kidney disease and is believed to contribute to a number of sequelae, including bone disease, altered protein metabolism, skeletal muscle wasting, and progressive glomerular filtration rate loss. Small trials in animal models and humans suggest a role for alkali therapy to lessen these complications. Recent studies support this notion, although more definitive evidence is needed on the long-term benefits of alkali therapy and the optimal serum bicarbonate level. The role of dietary modification also should be given greater consideration. In addition, potential adverse effects of alkali treatment must be taken into consideration, including sodium retention and the theoretical concern of promoting vascular calcification. This teaching case summarizes the rationale for and benefits and complications of base therapy in patients with chronic kidney disease.",
keywords = "alkali therapy, bicarbonate, chronic kidney disease, Metabolic acidosis",
author = "Wei Chen and Abramowitz, {Matthew K.}",
year = "2014",
month = "2",
doi = "10.1053/j.ajkd.2013.06.017",
language = "English (US)",
volume = "63",
pages = "311--317",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Treatment of metabolic acidosis in patients with CKD

AU - Chen, Wei

AU - Abramowitz, Matthew K.

PY - 2014/2

Y1 - 2014/2

N2 - Metabolic acidosis is a common complication of chronic kidney disease and is believed to contribute to a number of sequelae, including bone disease, altered protein metabolism, skeletal muscle wasting, and progressive glomerular filtration rate loss. Small trials in animal models and humans suggest a role for alkali therapy to lessen these complications. Recent studies support this notion, although more definitive evidence is needed on the long-term benefits of alkali therapy and the optimal serum bicarbonate level. The role of dietary modification also should be given greater consideration. In addition, potential adverse effects of alkali treatment must be taken into consideration, including sodium retention and the theoretical concern of promoting vascular calcification. This teaching case summarizes the rationale for and benefits and complications of base therapy in patients with chronic kidney disease.

AB - Metabolic acidosis is a common complication of chronic kidney disease and is believed to contribute to a number of sequelae, including bone disease, altered protein metabolism, skeletal muscle wasting, and progressive glomerular filtration rate loss. Small trials in animal models and humans suggest a role for alkali therapy to lessen these complications. Recent studies support this notion, although more definitive evidence is needed on the long-term benefits of alkali therapy and the optimal serum bicarbonate level. The role of dietary modification also should be given greater consideration. In addition, potential adverse effects of alkali treatment must be taken into consideration, including sodium retention and the theoretical concern of promoting vascular calcification. This teaching case summarizes the rationale for and benefits and complications of base therapy in patients with chronic kidney disease.

KW - alkali therapy

KW - bicarbonate

KW - chronic kidney disease

KW - Metabolic acidosis

UR - http://www.scopus.com/inward/record.url?scp=84892921362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892921362&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2013.06.017

DO - 10.1053/j.ajkd.2013.06.017

M3 - Article

C2 - 23932089

AN - SCOPUS:84892921362

VL - 63

SP - 311

EP - 317

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 2

ER -